AI’s shadow medical system| STAT
Every few weeks, another headline announces that artificial intelligence has matched a doctor, beaten a doctor, or is…
Google discontinued its Earth AI feature a day after its rollout after users made no-no images
Google spent years trying to weave generative AI into its product line up, from Gemini in our Google…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
America is running out of places to hang out as movie theaters, bars and diners drop to all-time low
Before I was a reporter covering the death of American fun, I tried to run on saving it.…
Europeans Are About to Find Out How Entrenched AI Is in Their Daily Lives
Advertisements, music recommendations, calendar management apps, and complaint hotlines—if they use AI, Europeans will need to be told.…
ChatGPT, Claude and other AI are transforming health care. Here is what you should ask your doctor.
AI is the hottest thing in medical care right now — but many of us feel trepidation about…
Artists are lawyering up against AI slop, and some are even winning
When The Atlantic published a searchable dataset of works used to train AI, Kirk Wallace Johnson, like a…
A new cholesterol pill could change the fight against heart disease
Last week, the Food and Drug Administration (FDA) approved a small pill called enlicitide. It is a tablet…
FDA is urged by advocacy group to ban DTC prescription drug ads
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
The science of foresight: how to future-proof your research
Every research programme is a bet on the future. Yet, scientists rarely examine the assumptions behind those bets.…
China delivers a one-two punch to America’s AI dominance
China’s leading AI companies are ramping up the pressure on Silicon Valley, as Moonshot and Alibaba unveiled models…
MARC Ratings raises Malaysia’s 2026 GDP growth forecast to 5.1%
KUALA LUMPUR: Malaysian Rating Corporation Bhd (MARC Ratings) has upgraded Malaysia’s 2026 gross domestic product (GDP) growth forecast to 5.1…